118 related articles for article (PubMed ID: 36642883)
21. Ellagic acid prevents rat colon carcinogenesis induced by 1, 2 dimethyl hydrazine through inhibition of AKT-phosphoinositide-3 kinase pathway.
Umesalma S; Sudhandiran G
Eur J Pharmacol; 2011 Jun; 660(2-3):249-58. PubMed ID: 21463623
[TBL] [Abstract][Full Text] [Related]
22. Discovery of ellagic acid as a competitive inhibitor of Src homology phosphotyrosyl phosphatase 2 (SHP2) for cancer treatment: In vitro and in silico study.
Ma CH; Zhao JF; Zhang XG; Ding CH; Hao HH; Ji YH; Li LP; Guo ZT; Liu WS
Int J Biol Macromol; 2024 Jan; 254(Pt 2):127845. PubMed ID: 37935292
[TBL] [Abstract][Full Text] [Related]
23. Ellagic acid inhibits VEGF/VEGFR2, PI3K/Akt and MAPK signaling cascades in the hamster cheek pouch carcinogenesis model.
Kowshik J; Giri H; Kishore TK; Kesavan R; Vankudavath RN; Reddy GB; Dixit M; Nagini S
Anticancer Agents Med Chem; 2014; 14(9):1249-60. PubMed ID: 25060902
[TBL] [Abstract][Full Text] [Related]
24. Rational drug discovery: Ellagic acid as a potent dual-target inhibitor against hepatitis C virus genotype 3 (HCV G3) NS3 enzymes.
Lim SK; Othman R; Yusof R; Heh CH
Chem Biol Drug Des; 2021 Jan; 97(1):28-40. PubMed ID: 32657543
[TBL] [Abstract][Full Text] [Related]
25. The effect of the phenol compound ellagic acid on Ca(2+) homeostasis and cytotoxicity in liver cells.
Liang WZ; Chou CT; Cheng JS; Wang JL; Chang HT; Chen IS; Lu T; Yeh JH; Kuo DH; Shieh P; Chen FA; Kuo CC; Jan CR
Eur J Pharmacol; 2016 Jun; 780():243-51. PubMed ID: 27038520
[TBL] [Abstract][Full Text] [Related]
26. In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cells.
Qiu Z; Zhou B; Jin L; Yu H; Liu L; Liu Y; Qin C; Xie S; Zhu F
Food Chem Toxicol; 2013 Sep; 59():428-37. PubMed ID: 23811531
[TBL] [Abstract][Full Text] [Related]
27. Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells.
Li TM; Chen GW; Su CC; Lin JG; Yeh CC; Cheng KC; Chung JG
Anticancer Res; 2005; 25(2A):971-9. PubMed ID: 15868936
[TBL] [Abstract][Full Text] [Related]
28. Ellagic acid inhibits oxidized low-density lipoprotein (OxLDL)-induced metalloproteinase (MMP) expression by modulating the protein kinase C-α/extracellular signal-regulated kinase/peroxisome proliferator-activated receptor γ/nuclear factor-κB (PKC-α/ERK/PPAR-γ/NF-κB) signaling pathway in endothelial cells.
Kuo MY; Ou HC; Lee WJ; Kuo WW; Hwang LL; Song TY; Huang CY; Chiu TH; Tsai KL; Tsai CS; Sheu WH
J Agric Food Chem; 2011 May; 59(9):5100-8. PubMed ID: 21480623
[TBL] [Abstract][Full Text] [Related]
29. Ellagic acid protects against carrageenan-induced acute inflammation through inhibition of nuclear factor kappa B, inducible cyclooxygenase and proinflammatory cytokines and enhancement of interleukin-10 via an antioxidant mechanism.
El-Shitany NA; El-Bastawissy EA; El-desoky K
Int Immunopharmacol; 2014 Apr; 19(2):290-9. PubMed ID: 24534771
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy.
Ali OM; Bekhit AA; Khattab SN; Helmy MW; Abdel-Ghany YS; Teleb M; Elzoghby AO
Colloids Surf B Biointerfaces; 2020 Apr; 188():110824. PubMed ID: 32023511
[TBL] [Abstract][Full Text] [Related]
31. Ellagic acid protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway.
Ou HC; Lee WJ; Lee SD; Huang CY; Chiu TH; Tsai KL; Hsu WC; Sheu WH
Toxicol Appl Pharmacol; 2010 Oct; 248(2):134-43. PubMed ID: 20691200
[TBL] [Abstract][Full Text] [Related]
32. Ellagic acid-loaded, tween 80-coated, chitosan nanoparticles as a promising therapeutic approach against breast cancer: In-vitro and in-vivo study.
Kaur H; Ghosh S; Kumar P; Basu B; Nagpal K
Life Sci; 2021 Nov; 284():119927. PubMed ID: 34492262
[TBL] [Abstract][Full Text] [Related]
33. Ellagic Acid Enhances the Efficacy of PI3K Inhibitor GDC-0941 in Breast Cancer Cells.
Shi L; Gao X; Li X; Jiang N; Luo F; Gu C; Chen M; Cheng H; Liu P
Curr Mol Med; 2015; 15(5):478-86. PubMed ID: 25941816
[TBL] [Abstract][Full Text] [Related]
34. Preparation of β-CD-Ellagic Acid Microspheres and Their Effects on HepG2 Cell Proliferation.
Wang H; Zhang Y; Tian Z; Ma J; Kang M; Ding C; Ming D
Molecules; 2017 Dec; 22(12):. PubMed ID: 29292740
[TBL] [Abstract][Full Text] [Related]
35. Computational assessment of chemicals from
Ugwah-Oguejiofor CJ; Chukwuka EP; Onifade OF; Agu ST; Adegboyega AE; Johnson GI; Ogunsuyi OI; Johnson TO
J Biomol Struct Dyn; 2023; 41(22):13271-13286. PubMed ID: 36709454
[TBL] [Abstract][Full Text] [Related]
36. A novel method to detect intracellular metabolite alterations in MCF-7 cells by doxorubicin induced cell death.
Kumar A; Patel S; Bhatkar D; Sarode SC; Sharma NK
Metabolomics; 2021 Jan; 17(1):3. PubMed ID: 33389242
[TBL] [Abstract][Full Text] [Related]
37. Discovery of natural product ellagic acid as a potent CD73 and CD39 dual inhibitor.
Wang Y; Wang C; Zhu Y; Zhang Y; Chen B; Wu Y; Yao J; Miao Z
Bioorg Med Chem Lett; 2021 Feb; 34():127758. PubMed ID: 33359608
[TBL] [Abstract][Full Text] [Related]
38. Ellagic acid, extracted from Sanguisorba officinalis, induces G1 arrest by modulating PTEN activity in B16F10 melanoma cells.
Tan YH; Shudo T; Yoshida T; Sugiyama Y; Si JY; Tsukano C; Takemoto Y; Kakizuka A
Genes Cells; 2019 Nov; 24(11):688-704. PubMed ID: 31495058
[TBL] [Abstract][Full Text] [Related]
39. Ellagic acid protects rat embryos in culture from the embryotoxic effects of N-methyl-N-nitrosourea.
Frank AA; Collier JM; Forsyth CS; Heur YH; Stoner GD
Teratology; 1992 Aug; 46(2):109-15. PubMed ID: 1440415
[TBL] [Abstract][Full Text] [Related]
40. Computational investigation of
Yousaf MA; Anwer SA; Basheera S; Sivanandan S
J Biomol Struct Dyn; 2024; 42(4):1901-1923. PubMed ID: 37154824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
